Does IFOSFAMIDE Cause Tumour marker increased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Tumour marker increased have been filed in association with IFOSFAMIDE (IFEX). This represents 0.0% of all adverse event reports for IFOSFAMIDE.
5
Reports of Tumour marker increased with IFOSFAMIDE
0.0%
of all IFOSFAMIDE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Tumour marker increased From IFOSFAMIDE?
Of the 5 reports, 1 (20.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IFOSFAMIDE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does IFOSFAMIDE Cause?
Off label use (2,281)
Febrile neutropenia (2,225)
Disease progression (1,912)
Neutropenia (1,509)
Drug ineffective (1,331)
Thrombocytopenia (1,227)
Anaemia (1,067)
Product use in unapproved indication (890)
Pyrexia (752)
Sepsis (712)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which IFOSFAMIDE Alternatives Have Lower Tumour marker increased Risk?
IFOSFAMIDE vs IGURATIMOD
IFOSFAMIDE vs ILOPERIDONE
IFOSFAMIDE vs ILOPROST
IFOSFAMIDE vs IMATINIB
IFOSFAMIDE vs IMBRUVICA